Loomis AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
142 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
January 29, 2018 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 11, 2018 | Contour Asset Management | 1.60% | still open |
| October 3, 2018 | Marshall Wace LLP | 0.79% | still open |
| October 2, 2018 | Contour Asset Management | 1.58% | still open |
| October 2, 2018 | Marshall Wace LLP | 0.79% | still open |
| October 1, 2018 | Contour Asset Management | 1.58% | still open |
| September 24, 2018 | Carmignac Gestion | 0.50% | still open |
| September 23, 2018 | Carmignac Gestion | 0.50% | still open |
| September 7, 2018 | Marshall Wace LLP | 0.80% | still open |
| September 6, 2018 | Marshall Wace LLP | 0.80% | still open |
| September 4, 2018 | Contour Asset Management | 1.62% | still open |
| September 3, 2018 | Contour Asset Management | 1.53% | still open |
| September 3, 2018 | Marshall Wace LLP | 0.71% | still open |
| September 3, 2018 | Marshall Wace Asia Limited | 0.60% | still open |
| September 2, 2018 | Contour Asset Management | 1.53% | still open |
| September 2, 2018 | Marshall Wace LLP | 0.71% | still open |
| September 2, 2018 | Marshall Wace Asia Limited | 0.60% | still open |
| August 1, 2018 | Marshall Wace LLP | 0.69% | still open |
| July 31, 2018 | Marshall Wace LLP | 0.69% | still open |
| July 26, 2018 | Marshall Wace LLP | 0.73% | still open |
| July 26, 2018 | Marshall Wace Asia Limited | 0.51% | still open |
| July 25, 2018 | Marshall Wace LLP | 0.73% | still open |
| July 25, 2018 | Marshall Wace Asia Limited | 0.51% | still open |
| July 9, 2018 | Marshall Wace LLP | 0.60% | still open |
| July 8, 2018 | Marshall Wace LLP | 0.60% | still open |
| June 29, 2018 | Marshall Wace LLP | 0.50% | still open |
| June 28, 2018 | Marshall Wace LLP | 0.50% | still open |
| June 15, 2018 | Contour Asset Management | 1.40% | still open |
| June 14, 2018 | Contour Asset Management | 1.33% | still open |
| June 13, 2018 | Contour Asset Management | 1.33% | still open |
| June 7, 2018 | Contour Asset Management | 1.23% | still open |
| June 6, 2018 | Contour Asset Management | 1.23% | still open |
| June 5, 2018 | Contour Asset Management | 1.18% | still open |
| June 4, 2018 | Contour Asset Management | 1.09% | still open |
| June 3, 2018 | Contour Asset Management | 1.09% | still open |
| May 7, 2018 | Contour Asset Management | 0.90% | still open |
| May 6, 2018 | Contour Asset Management | 0.90% | still open |
| May 4, 2018 | Contour Asset Management | 0.83% | still open |
| May 3, 2018 | Contour Asset Management | 0.67% | still open |
| May 2, 2018 | Contour Asset Management | 0.67% | still open |
| January 31, 2018 | Henderson Global Investors Limited | 0.00% | still open |
| January 30, 2018 | Henderson Global Investors Limited | 0.52% | still open |
| January 29, 2018 | Henderson Global Investors Limited | 0.52% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Loomis AB, source Finansinspektionen, data as at December 16, 2022, https://www.quivad.com/action/loomis-ab?page=3